Revolutionising patient-centric care: Myeloma UK’s groundbreaking research at BSH

Myeloma UK’s health services research team (HSR) had a prominent presence at the British Society of Haematology (BSH) Annual Conference in Birmingham this year, showcasing their groundbreaking research.

With a strong focus on addressing the unmet needs of patients, HSR presented their findings on shared decision-making, imaging at myeloma diagnosis, and patient-centric care.

Details

AL amyloidosis

In AL amyloidosis, amyloid fibrils, composed of abnormal light chain proteins, are produced by abnormal plasma cells in the bone marrow. AL amyloidosis is a plasma cell disorder but as the plasma cells are not truly cancerous, it is not regarded as a cancer. It is however closely related to myeloma and is diagnosed in…

Details

Plasma Cell Disorders Webinar Series: Journey from Laboratory Tests to Diagnosis

Laboratory staff play a key role in the investigation, diagnosis, and management of a range of plasma cell disorders including MGUS, AL amyloidosis and myeloma. In March 2023, we partnered with UKNEQAS to deliver four educational webinars covering these disorders. The webinars focus on defining the different types of plasma cell disorders, deciding when and…

Details

STOP-Bang Questionnaire

The following questionnaire can determine if you are at risk of developing obstructive sleep apnea (OSA) by screening for 4 self-reportable and 4 demographic characteristics. Note this is Property of the University Health Network. Modified from Chung F et al. Anesthesiology 2008; 108: 812-821, Chung F et al Br J Anaesth 2012; 108: 768-775, Chung…

Details